FIA
AKRO

FNY Investment Advisers’s Akero Therapeutics AKRO Stock Holding History

FNY Investment Advisers’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-293
Closed -$13K – 908
2025
Q3 		$13K Sell
293
-242
-45% -$11.7K ﹤0.01% 748
2025
Q2 		$28K Buy
+535
New +$24.3K 0.01% 508

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's AKRO Position: Q4 2025 in Review

FNY Investment Advisers sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 293 shares — an estimated $13K sold.

FNY Investment Advisers first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $28K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • FNY Investment Advisers reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 293 Akero Therapeutics shares in Q4 2025, an estimated $13K.
  • FNY Investment Advisers first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Akero Therapeutics position peaked at $28K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.